Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Amikik, our order are going by on "CNBC" BOTTOM BAR. That is a good thing. Maybe we will get some action once NWBO get back in the green. I'am going to try call NorthWest bio to see can we get some more help this morning in keeping our pps up. There it goes again, going by on "CNBC" 54.
Good Luck to everybody today. Let's get get our pps up much higher and it stays there.
Damn, I waiting for a sell to go thru on another stock so I could use the funds to hit the ask over here while it was .686, and I be damn somebody hit that low bid and bought it down to .5016. I hope it wasn't Al wife. Peeps don't mind hitting the bid, but if you don't hit that ask early in pre market, or at lease put an higher bid in. Shorts or wanna get out at any price shareholders can bring the pps down really quick. It only take a few shares to bring down the pps. I might as well cancer that order.
I'am up now. I was worried about the big drop in share price. Especially when it went below .56 this even. I thought it was the shorts, and Mr Frankenstein and his gooneys being very nasty.Trying their best to keep DCVax-L and DCVax Direct from making it to the consumers market to help the patients that really need this med. But thank God is was just Algorithm wife kicking his but thru his wallet. I saw those after hour sells go thru 5000, 4000, 5000, and so on taking the pps under .56 cents. Some commented here said that trigger stop losses. We know stop losses can drag a pps down very fast, but we will recover today.
We're invested in a great product. I hoping NorthWest Bio release the name of their new partner and the updates of phase III clinical trial this morning before the market open. Everyone who can call the company in the morning and ask them to release the updates on phase III brain cancer clinical trial like they say they will. Well I'am going to go back to sleep, now that I know Al wife was the one to trigger the stop losses. I'am so glad I'am free from a angry spouse. LOL.
Northwest bio has 2 different clinical study trials using DCVax-L 1) Protocol 020221 Expanded the Access for GBM Patients with already Manufactured DCVax-L for patients who have scree-failed Protocol. Who is not eligible for the Enrollment due to diseases, but will be part of the clinical study(Open Label Vaccine) Esimate Enrollment 99
2) For qualified enrollment for the study of a drug (DCVax-L) to treat newly diagnose patients with GBM Brain Cancer Clinical trial NCT00045968. Estimated Enrollment 348
I didn't know NorthWest Bio have 2 different types of enrollments for GBM brain cancer clinical trial. They each has their own enrollments with a different number of Patients to be enroll in each study. The studies has been going on for over 2 years almost 2 and half years. I understand this study very clearly now. Just because some of the patients did not qualify for the newly diagnose brain cancer enrollment, because they was ill with some other type of illness, or the cancer has made them very sick, and the cancer has grown. They still could be part of another enrollment that would allow them access to the brain cancer treatment drug (vaccine) DCVax-L and still be part of the study. maybe how well the drug work on Patients who are ill and have been diagnose with cancer and treated for a while with some other type of cancer treatment. Plus those treatment with some other type of cancer drug or therapy it did or did not work, or they need the the open label vaccine to see will this help to treat their brain cancer.
This GBM brain cancer clinical studies is becoming very interesting. We are definitely due for an update on how well this has been going.
That is not what it is stating. Let me do my best in giving the board the truth of what it is stating.
1. It is called: The Expanded the Access for GBN PATINENTS WITH ALREADY MANUFACTURE DCVax-l, WHO HAVE SCREEM-FAILED PROTOCAL 020221. FOR PATIENTS WHO IS NOT ELIGIBLE FOR ENROLLMENT DUE to DISEASE.
2. THE PATIENTS WHO ARE NOT ELIGIBLE FOR ENROLLMENT CAN STILL RECEIVED THEIR DCVax-L WITH STARDARD MEDICAL CARE.
3. EXPECTED TO ENROLL 99 PATIENTS.
4. LAST UPDATE: February 25, 2016
My input on this info DCVax-L is on its way to APPROVAL.
NorthWest need to release that monstrous pr that will bury those shorts once and for all. Mr Frankenstein from the street came and bashed. Seem like Every time NorthWest Bio release a great PR here he come with his negative comments. He never have anything good to say about NWBO. I hope Northwest get a very good professional to write their next PR. They letting that monster from the street tear this company down.
Let's Go NWBO!!
NorthWest to give update on DCVax-L phase III clinical trial results. I heard word is out about a possible merger coming from the company.
Since NWBO is almost at the completion of it DCVax-L phase III clinical trial I 'am hoping Bristol Meyers still like to merge with Northwest bio. They have the funds and NWBO has a product almost ready for FDA approval. BMY has been looking for a company with a develop cancer vaccine with great potential of getting a FDA approval. NorthWest bio is the best candidate for that type of Merger. NWBO is the only company that has a phase III clinical trial cancer vaccine drug study near completion.
NorthWest Bio DCVax-L is favorable of getting a FDA approval for marketing.
Buy you can have it. Good Luck with boats during hurricane season. My new day job is being the listener to what shareholders are commenting about, tracking and researching info for myself and shareholders, being the opposite of bad comment bullying on a stock message board, especially if what their are saying is not true. I love this job I gave myself.
Little they know Northwest bio have just a little ways to go to apply for FDA approval for DCVax-L, because they have made it over the big stumbling blocks and hurdlers. Just a few pot holes in the road and they will go around them. Then it is a smooth ride all the way to Approval. IMO the more close NWBO gets to approval the more negative the comments become. those negative comments will not stop DCVax-L, FDA approval.
MD, NWBO will resume patient enrollment for DCVax-L phase III clinical trial or summit forms for FDA approval. It is one or the other. No errors has been found if so we would have known it by now. NorthWest is going to get its approval for DCVax-L.
Little guy I made my millions years ago, years ago. And it was before I ever invested money on my own in the stock market. I don't need to pump a stock to get paid, I have already been paid. I'am 47 and has been retired for 12 years. After 6 months of retirement it becomes very boring. All your friends are still working and you are at home, because you run out of thing to do. even boating becomes boring, playing golf hurts. I do trading and investing as a hobby, and yes to get paid, and I love it. Back to pumping if I wanted to pump this stock I would have and gotten out when it went as high as .76 cents a share. I didn't sell not one share, I have been holding from the very low 40's. Yes it is true when I first came here, because of another told my board about this stock, and yes I first traded NWBO, now I'am here to be part of the first approve cancer immune vaccine drug. I believe DCVax-L is going to get approved.
Thank you 29yearinvestor. How about this Linda Powers can you take a call from Bristol Myers, Pfizer, Merch, Roche, and so many others who want Northwest FDA approve DCVax-L cancer immune vaccine. You guys know we're going to get that FDA approval.
Let's Go NorthWest Bio.
I'm thinking about the moment the world learn that a small biotech like NorthWest biotherapeutics came out with the first immune vaccine drug DCVax-l for brain cancer has been approve by the FDA. You guys know we're going to get that approval. Plus in the future DCVax Direct will also be getting a FDA approval.
I agree. The FDA could come out with very good news for NWBO DCVax-L clinical trials for the pass 10 years and give them a Go. Northwest bio has been reporting very good clinical data thru out the clinical trial. Either the FDA is going to let them complete the patient enrollment into the clinical study, or tell NWBO there is no need for anymore clinical study we're going to approve the drug DCVax-L. Get all necessary paper work and summit it for DCVax-L approval. Many know the FDA or looking over their pass 10 year study with a fine tooth comb. If any errors was there they would have found it by now. IMO the only thing they've found is excellent follow thru procedures and data.
Oh no, that is not me saying that is was or ever been halted. I read that junk on this board. I'am one who believe that the DCVax-L treatment drug for brain cancer clinical trial is ongoing and near completion, and it has a very good chance of getting a FDA approval once completed. I would like to see a present updates on Phase III clinical trail for brain cancer. It has been over 6 months since NorthWest bio release an update on DCVax-L drug to treat brain cancer phase III clinical trial I believe the last date was February 2, 2016. IMO the phase III clinical trial for brain cancer is going to be NorthWest Biotherapeutics, Inc conference Grand [/b]Finale . It has been over 10 years since the company started this clinical study for a vaccine for Brain Cancer.
I think DCVax-L has a very Good chance of getting a FDA approval. I really do hope so. They're near the completion of the Brain Cancer phase III clinical trials. Plus the Clinical Trial Government processed this record today September 21, 2016, and I did took notice of the estimated primary completion Date: September 2016, that has not change. The paperwork did not state that the GBM clinical trial is still halted. Its show in red that the clinical trial is still on going, and not recruiting participants.
NWBO stated today all updates was not reported in today's pr. We will get an update of phase III brain cancer (GBH) clinical trial.
https://clinicaltrials.gov/ct2/show/NCT00045968
Posted by Government on September 21, 2016
JT, very soon, I don't know if it is going to be at the end of the Conferences. But one thing said, "is not all trial updates was reported in todays pr", and updates on DCVaxl brain cancer study will be release. The way he expressed the phrase " will be release" he said it in a tone like yes, it's definitely going to be release, he said it in a vigorous happy and pride tone, but those are my words and interpretation of his tone of voice. Who knows they might have a big partner lined up to help to complete phase III continue trial study. IMO Something big is happening with DCVax-L phase III. I think we could be in for a mighty big surprise. I really don't know what it is, but I do believe something good is going to happen involving the development of the brain cancer treatment DCVax-L.
Let us all hope we will get an answer very soon like tomorrow.
DCVax-L that is being save for the Grand finale.
Hold onto your horses we're going to get that pr.
The late pr we received today is not the only pr we will be receiving according to Norhtwest bio representative. I ask what in the hell happen to all the other updates especially DCVax-L Phase III continuing updates for the patients being studied for brain cancer using DCVax-l. Updates on DCVax brain cancer trial will be release. Not all trial updates was reported in today's pr, stated the NWBO representative who answered the phone after I have left about 20 plus messages today. I told he that I'am very pissed at how awful Northwest handle its shareholders today, by not release updated info before the London conference today.
Again as stated by NorthWest Biotherapeutics representative "update on DCVax brain cancer trial will be release. Not all trial updates was reported in today's pr".
I agree their are living longer. I'am just waiting for NorthWest bio to release this information. And what about the patients that has been in the continue trial studies for 11 years. What is the update on their progress, and are they still cancer free. Plus have there been other patients who has reach this level of prognosis. This info should be updated and made available on the companies website. We need more than just a simple pr.
Under covered Hedge funds. That is who their are. They've been bashing at this every since it got start. For the big pharma folks. Don't let them get to you. We know what we own. Northwest Bio study team and researchers, plus patients has gave great reports on the study of DCVax-L. That is probably the reason Northwest bio 2015 video about DCVax-L was taking down off of YOUTUBE. but that can't stop the facts of how the brain cancer treatment has help many of the patient in the trial studies live longer when given DCVax-L. We will get the latest reports and updates of the trial studies today.
IMO I think DCVax-L does both it prolong lives and for some a cure (save and extend lives). Especially since some of the patients from the beginning of the first trial study thru the third trial plus the continue trial study is still here and living productive and active lives. We will know more tomorrow.
News could come at anytime, because London time is 5 hours ahead of the US market time. A PR should be release to the US markets before, the start of the conference in London. According to the SEC market rules for IPO reporting companies.
We will see Linda name on the Press Releases
There will be lots of positive news about NorthWest other studies that will be presented in the conference. Northwest is expected to have positive news from different areas. I have a feeling NorthWest Bio might release some of trial findings results news today.
I agree with you 100% Spartex. The bridge to chemo will be falling shortly after the conference in London tomorrow. No more using chemo poison to help fight brain cancer. A better treatment will be hitting the markets very soon, one that will not poison a patient and make them very sick while being treated. DCVax-L will be a more acceptable treatment for the body without causing most of the side effects as chemo. I'am looking forward to the conference tomorrow.
The best parts I research about DCVax-L treatment for brain cancer is that many of the patient are living longer and active lives by using DCVax-L. This is very important that NorthWest Bio has put this information onto their website. And Patients talking about their treatment with DCVax-L and how it is helping them.
Good Job NorthWest Health staff and study team.
No it won't be falling. NorthWest DCVax-L will give many brain and non brain cancer Patients and their love ones hope. Hope for a chance to get well and live a long life.
The News on the patients who was diagnose with brain cancer and treated with NorthWest Bio med DCVax-L 10 years ago. They have been in the studies from Phase 1 of the study trial thru phase III and the continue trial. The patients are still living and living productive active lives. They will be the main topic in tomorrow conference in London.
NorthWest Bio could be the next CPXX and TBRA to get bought out.
NorthWest Bio DCVax-L Brain Cancer Treatment is Helping Patients live 6 and pass 10 years when life expediency is just 8.9 months to 14.9 months without it. Northwest Bio has a very good Cancer Treatment. Their Website shows the progress of patient from Phase 1 to phase 111 who are using DCVax-L living loner productive lives. Less Go NWBO !!
NEWS OUT at ANYTIME Today or before Conference Tomorrow Morning in London.
We can get that $1.00 today, and when news hit today or before Pre Market tomorrow we can go straight to $2 before the market open.
Waiting on the news to drop between now and before the conference start tomorrow.
Amda is next for approval.
Thank you. I have 2 more that I'am in also waiting for FDA approval and a buyout.
I'am so glad I pick this stock up yesterday. Only 500 shares, but WOW.
Finally the SEC is protecting the little guy from what use to be a very good stock, that has turned into a Big...S C A M !!.
And I subject that all shorties should cover before the train leave the station. Just cover shorts.
Cover shorts. The train is leaving the station. Last chance to get on board. NorthWest Bio DCVax-L will make the market headlines.